Slip Disc Market information, by types (thoracic herniated discs, lumbar herniated disc, and others), by diagnosis (physical examination, nerve conduction test, and others), by treatment (medications, therapy, and others) - global forecast till 2030
ID: MRFR/MED/2785-CR | 108 Pages | Published By Rahul Gotadki on August 2017
1 Report Prologue
2 Introduction
2.1 Introduction
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
3 Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Drivers
4.1.1 Growing Cases of Spinal Injuries
4.1.2 Growing awareness of spinal non-fusion procedures
4.1.3 Growing Adoption of Sedentary Lifestyle
4.1.4 Growing Prevalence of Obese Population Affecting Spinal Injuries
4.2 Restrains
4.2.1 Treatment Cost
4.2.2 Ethical and Social Concerns
4.2.3 Complications Involved
4.3 Opportunities
4.3.1 Development of New Alternative Treatment Method
4.3.2 Botulinum-A Toxin Injections for Treatment Spinal Cord Injuries
5 Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Introduction
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of New Entrants
5.1.5 Threat of Substitutes
5.1.6 Intensity of Rivalry
5.2 Value Chain Analysis
5.2.1 Introduction
5.2.2 Primary Activities
5.2.3 Secondary Activities
6 Global Slip disc market by Types
6.1 Introduction
6.2 Thoracic Herniated Discs
6.3 Lumbar Herniated Disc
6.4 Cervical Herniated Discs
7 Slip Disc Market, By Diagnosis
7.1 Introduction
7.2 Physical Examination
7.3 Nerve Conduction Test
7.4 Imaging Tests
8 Slip Disc Market, By Treatment
8.1 Introduction
8.2 Medications
8.3 Therapy
8.4 Surgery
9 Global Slip Disc Market, By Regions
9.1 Introduction
9.2 Americas
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.2.1 Americas
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.2.1.1 US
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.2.1.2 Canada
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.2.2 Latin America
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3 Europe
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.1 Germany
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.2 France
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.3 UK
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.4 Italy
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.5 Spain
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.3.6 Rest of Europe
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4 Asia Pacific
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.1 Japan
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.2 China
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.3 India
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.4 Republic of Korea
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.5 Australia
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.4.6 Rest of Asia Pacific
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.5 Middle East & Africa
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.5.1 Middle East
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
9.5.2 Africa
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
10 Competitive landscape
Slip Disc Market, By Diagnosis
Slip Disc Market, By Treatment
10.1 Introduction
10 Competitive landscape
10.1 Introduction
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Updates
11.1.4 Key Developments
11.2 TEVA Pharmaceutical LTD.
11.2.1 Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financials
11.2.4 Key Developments
11.3 GlaxoSmithKline plc.
11.3.1 Company Overview
11.3.2 Product overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 DePuy Synthes Companies (Part of Johnson & Johnson Services, Inc.)
11.4.1 Company Overview
11.4.2 Product Overview
11.4.3 Key Developments
11.4.4 Financials
11.4.5 SWOT Analysis
11.5 NuVasive, Inc.
11.5.1 Overview
11.5.2 Product Overview
11.5.3 Financials
11.5.4 Key Developments
11.6 Captiva Spine, Inc.
11.6.1 Overview
11.6.2 Product Overview
11.6.3 Financials
11.6.4 Key Development
11.7 Globus Medical, Inc.
11.7.1 Overview
11.7.2 Product Overview
11.7.3 Financials
11.7.4 Key Developments
